Selected article for: "critical case and disease severity"
Author: Pang, Qi-Lin; He, Wen-Cheng; Li, Jin-Xiu; Huang, Lei
Title: Symptomatic and optimal supportive care of critical COVID-19: A case report and literature review
  • Cord-id: r5jco7tp
  • Document date: 2020_12_6
    • ID: r5jco7tp
    Snippet: BACKGROUND: Coronavirus disease 2019 (COVID-19) severity is classified as asymptomatic, mild, moderate, severe, and critical. Mild cases account for a large percentage of cases in the epidemic and typically exhibit a favorable prognosis. However, a 49%-67% mortality is noted in critical cases. No COVID-19-specific drug has been reported to date, and symptomatic and optimal supportive care, including oxygenation, anti-coinfection treatments, and ventilation, represent the mainstay of treatment fo
    Document: BACKGROUND: Coronavirus disease 2019 (COVID-19) severity is classified as asymptomatic, mild, moderate, severe, and critical. Mild cases account for a large percentage of cases in the epidemic and typically exhibit a favorable prognosis. However, a 49%-67% mortality is noted in critical cases. No COVID-19-specific drug has been reported to date, and symptomatic and optimal supportive care, including oxygenation, anti-coinfection treatments, and ventilation, represent the mainstay of treatment for this disease, especially in critical patients. CASE SUMMARY: In the above-mentioned context, we share our experience with the treatment of one critical COVID-19 case and review the relevant literature. CONCLUSION: Timely tracheal intubation, reasonable mechanical ventilation support, appropriate anti-infection treatment, and early anticoagulation and immunity support are key factors in the successful treatment of this case.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and admission follow: 1, 2
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lopinavir ritonavir tablet: 1
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and low tidal volume: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and low ventilator: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and lung alveolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute renal injury and lopinavir ritonavir: 1, 2
    • acute renal injury and low molecular weight heparin: 1, 2
    • acute renal injury and low ventilator: 1
    • acute renal injury and lung alveolar: 1, 2
    • admission follow and lopinavir ritonavir: 1, 2
    • admission follow and low molecular weight heparin: 1, 2
    • lopinavir ritonavir and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7